» Articles » PMID: 23565812

Expressional Alterations in Functional Ultra-conserved Non-coding RNAs in Response to All-trans Retinoic Acid--induced Differentiation in Neuroblastoma Cells

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2013 Apr 10
PMID 23565812
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Ultra-conserved regions (UCRs) are segments of the genome (≥ 200 bp) that exhibit 100% DNA sequence conservation between human, mouse and rat. Transcribed UCRs (T-UCRs) have been shown to be differentially expressed in cancers versus normal tissue, indicating a possible role in carcinogenesis. All-trans-retinoic acid (ATRA) causes some neuroblastoma (NB) cell lines to undergo differentiation and leads to a significant decrease in the oncogenic transcription factor MYCN. Here, we examine the impact of ATRA treatment on T-UCR expression and investigate the biological significance of these changes.

Methods: We designed a custom tiling microarray to profile the expression of 481 T-UCRs in sense and anti-sense orientation (962 potential transcripts) in untreated and ATRA-treated neuroblastoma cell lines (SH-SY5Y, SK-N-BE, LAN-5). Following identification of significantly differentially expressed T-UCRs, we carried out siRNA knockdown and gene expression microarray analysis to investigate putative functional roles for selected T-UCRs.

Results: Following ATRA-induced differentiation, 32 T-UCRs were differentially expressed (16 up-regulated, 16 down-regulated) across all three cell lines. Further insight into the possible role of T-UC.300A, an independent transcript whose expression is down-regulated following ATRA was achieved by siRNA knockdown, resulting in the decreased viability and invasiveness of ATRA-responsive cell lines. Gene expression microarray analysis following knockdown of T-UC.300A revealed a number of genes whose expression was altered by changing T-UC.300A levels and that might play a role in the increased proliferation and invasion of NB cells prior to ATRA-treatment.

Conclusions: Our results indicate that significant numbers of T-UCRs have altered expression levels in response to ATRA. While the precise roles that T-UCRs might play in cancer or in normal development are largely unknown and an important area for future study, our findings strongly indicate that the function of non-coding RNA T-UC.300A is connected with proliferation, invasion and the inhibition of differentiation of neuroblastoma cell lines prior to ATRA treatment.

Citing Articles

The expression and function of long noncoding RNAs in hepatocellular carcinoma.

Du J, Su Y, Gao J, Tai Y Cancer Innov. 2023; 2(6):488-499.

PMID: 38125766 PMC: 10730004. DOI: 10.1002/cai2.90.


Transcribed Ultraconserved Regions: New regulators in cancer signaling and potential biomarkers.

de Oliveira J Genet Mol Biol. 2023; 46(1 Suppl 2):e20220125.

PMID: 36622962 PMC: 9829027. DOI: 10.1590/1678-4685-GMB-2022-0125.


Non-Coding RNAs Participate in the Pathogenesis of Neuroblastoma.

Rezaei O, Tamizkar K, Hajiesmaeili M, Taheri M, Ghafouri-Fard S Front Oncol. 2021; 11:617362.

PMID: 33718173 PMC: 7945591. DOI: 10.3389/fonc.2021.617362.


Ultraconserved long non-coding RNA uc.112 is highly expressed in childhood T versus B-cell acute lymphoblastic leukemia.

das Chagas P, de Sousa G, Kodama M, de Biagi Junior C, Yunes J, Brandalise S Hematol Transfus Cell Ther. 2020; 43(1):28-34.

PMID: 32014474 PMC: 7910170. DOI: 10.1016/j.htct.2019.12.003.


Identification of lncRNAs Associated With Neuroblastoma in Cross-Sectional Databases: Potential Biomarkers.

Prajapati B, Fatma M, Fatima M, Khan M, Sinha S, Seth P Front Mol Neurosci. 2020; 12:293.

PMID: 31920530 PMC: 6920248. DOI: 10.3389/fnmol.2019.00293.


References
1.
Moran A, Fernandez-Marcelo T, Carro J, De Juan C, Pascua I, Head J . Methylation profiling in non-small cell lung cancer: clinical implications. Int J Oncol. 2011; 40(3):739-46. DOI: 10.3892/ijo.2011.1253. View

2.
Gnarra J, Dressler G . Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides. Cancer Res. 1995; 55(18):4092-8. View

3.
Vermeulen J, De Preter K, Naranjo A, Vercruysse L, Van Roy N, Hellemans J . Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study. Lancet Oncol. 2009; 10(7):663-71. PMC: 3045079. DOI: 10.1016/S1470-2045(09)70154-8. View

4.
Calin G, Liu C, Ferracin M, Hyslop T, Spizzo R, Sevignani C . Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell. 2007; 12(3):215-29. DOI: 10.1016/j.ccr.2007.07.027. View

5.
McArdle L, McDermott M, Purcell R, Grehan D, OMeara A, Breatnach F . Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q. Carcinogenesis. 2004; 25(9):1599-609. DOI: 10.1093/carcin/bgh173. View